Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Amortization of Goodwill (2023 - 2025)

Historic Amortization of Goodwill for Definitive Healthcare (DH) over the last 3 years, with Q1 2025 value amounting to $176.5 million.

  • Definitive Healthcare's Amortization of Goodwill changed N/A to $176.5 million in Q1 2025 from the same period last year, while for Sep 2025 it was $273.6 million, marking a year-over-year decrease of 5376.61%. This contributed to the annual value of $688.9 million for FY2024, which is 13970.08% up from last year.
  • Definitive Healthcare's Amortization of Goodwill amounted to $176.5 million in Q1 2025.
  • Definitive Healthcare's Amortization of Goodwill's 5-year high stood at $363.6 million during Q2 2024, with a 5-year trough of $97.1 million in Q4 2024.
  • In the last 3 years, Definitive Healthcare's Amortization of Goodwill had a median value of $228.2 million in 2024 and averaged $230.6 million.
  • The largest annual percentage gain for Definitive Healthcare's Amortization of Goodwill in the last 5 years was 2059.85% (2024), contrasted with its biggest fall of 2059.85% (2024).
  • Quarter analysis of 3 years shows Definitive Healthcare's Amortization of Goodwill stood at $287.4 million in 2023, then crashed by 66.21% to $97.1 million in 2024, then skyrocketed by 81.8% to $176.5 million in 2025.
  • Its last three reported values are $176.5 million in Q1 2025, $97.1 million for Q4 2024, and $228.2 million during Q3 2024.